Murigenetics Overview

  • Founded
  • 2005
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A

Murigenetics General Information

Description

Operator of an biotechnology company developing therapies for genetic disorders. The company provides molecule research and drugs for dealing genetic diseases, cell models for rare diseases and genetic disorders.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly Accelerator/Incubator backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Acquirer
Primary Office
  • 10 Clapier Street
  • 13001 Marseille
  • France
+33 04 00 00 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Murigenetics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition Completed Startup
1. Accelerator/Incubator Completed Startup
To view Murigenetics’s complete valuation and funding history, request access »

Murigenetics Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Incubateur Impulse Accelerator/Incubator 000 0000 000000 0
To view Murigenetics’s complete investors history, request access »